Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD56, HLA-DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3-GLIS2 fusion transcript.
Zangrando A, Cavagnero F, Scarparo P, Varotto E, Francescato S, Tregnago C, Cuccurullo R, Fagioli F, Nigro LL, Masetti R, Putti MC, Rizzari C, Santoro N, Pession A, Pigazzi M, Locatelli F, Basso G, Buldini B. Zangrando A, et al. Among authors: buldini b. Cytometry A. 2021 Aug;99(8):844-850. doi: 10.1002/cyto.a.24339. Epub 2021 Apr 2. Cytometry A. 2021. PMID: 33811445 Free PMC article.
Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience.
Lovisa F, Gallingani I, Varotto E, Pasin C, Carraro E, Michielotto B, Garbin A, Damanti CC, Pizzi M, d'Amore ESG, Piglione M, Muggeo P, Buffardi S, Vinti L, Folsi VM, Onofrillo D, Biffi A, Buldini B, Pillon M, Mussolin L. Lovisa F, et al. Among authors: buldini b. Diagnostics (Basel). 2021 Sep 1;11(9):1594. doi: 10.3390/diagnostics11091594. Diagnostics (Basel). 2021. PMID: 34573936 Free PMC article.
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report.
Maurer-Granofszky M, Schumich A, Buldini B, Gaipa G, Kappelmayer J, Mejstrikova E, Karawajew L, Rossi J, Suzan AÇ, Agriello E, Anastasiou-Grenzelia T, Barcala V, Barna G, Batinić D, Bourquin JP, Brüggemann M, Bukowska-Strakova K, Burnusuzov H, Carelli D, Deniz G, Dubravčić K, Feuerstein T, Gaillard MI, Galeano A, Giordano H, Gonzalez A, Groeneveld-Krentz S, Hevessy Z, Hrusak O, Iarossi MB, Jáksó P, Kloboves Prevodnik V, Kohlscheen S, Kreminska E, Maglia O, Malusardi C, Marinov N, Martin BM, Möller C, Nikulshin S, Palazzi J, Paterakis G, Popov A, Ratei R, Rodríguez C, Sajaroff EO, Sala S, Samardzija G, Sartor M, Scarparo P, Sędek Ł, Slavkovic B, Solari L, Svec P, Szczepanski T, Taparkou A, Torrebadell M, Tzanoudaki M, Varotto E, Vernitsky H, Attarbaschi A, Schrappe M, Conter V, Biondi A, Felice M, Campbell M, Kiss C, Basso G, Dworzak MN, On Behalf Of I-Bfm-Flow-Network. Maurer-Granofszky M, et al. Among authors: buldini b. Cancers (Basel). 2021 Dec 6;13(23):6148. doi: 10.3390/cancers13236148. Cancers (Basel). 2021. PMID: 34885257 Free PMC article.
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia.
Veltri G, Lovisa F, Cortese G, Pillon M, Carraro E, Cesaro S, Provenzi M, Buffardi S, Francescato S, Biffi A, Buldini B, Conter V, Serafin V, Mussolin L. Veltri G, et al. Among authors: buldini b. Front Oncol. 2022 Jul 8;12:913487. doi: 10.3389/fonc.2022.913487. eCollection 2022. Front Oncol. 2022. PMID: 35875136 Free PMC article.
CD72 is a pan-tumor antigen associated to pediatric acute leukemia.
Buldini B, Faggin G, Porcù E, Scarparo P, Polato K, Tregnago C, Varotto E, Rizzardi P, Rizzari C, Locatelli F, Biffi A, Pigazzi M. Buldini B, et al. Cytometry A. 2023 Dec;103(12):1004-1009. doi: 10.1002/cyto.a.24790. Epub 2023 Oct 24. Cytometry A. 2023. PMID: 37876342
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
Buldini B, Varotto E, Maurer-Granofszky M, Gaipa G, Schumich A, Brüggemann M, Mejstrikova E, Cazzaniga G, Hrusak O, Szczepanowski M, Scarparo P, Zimmermann M, Strehl S, Schinnerl D, Zaliova M, Karawajew L, Bourquin JP, Feuerstein T, Cario G, Alten J, Möricke A, Biffi A, Parasole R, Fagioli F, Valsecchi MG, Biondi A, Locatelli F, Attarbaschi A, Schrappe M, Conter V, Basso G, Dworzak MN. Buldini B, et al. Blood. 2024 Apr 25;143(17):1738-1751. doi: 10.1182/blood.2023021952. Blood. 2024. PMID: 38215390
Relative expansion of CD19-negative very-early normal B-cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR-T cell therapy: implications for flow cytometric detection of minimal residual disease.
Mikhailova E, Semchenkova A, Illarionova O, Kashpor S, Brilliantova V, Zakharova E, Zerkalenkova E, Zangrando A, Bocharova N, Shelikhova L, Diakonova Y, Zhogov V, Khismatullina R, Molostova O, Buldini B, Raykina E, Larin S, Olshanskaya Y, Miakova N, Novichkova G, Maschan M, Popov AM. Mikhailova E, et al. Among authors: buldini b. Br J Haematol. 2021 May;193(3):602-612. doi: 10.1111/bjh.17382. Epub 2021 Mar 14. Br J Haematol. 2021. PMID: 33715150
Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
Borella G, Da Ros A, Borile G, Porcù E, Tregnago C, Benetton M, Marchetti A, Bisio V, Montini B, Michielotto B, Cani A, Leszl A, Campodoni E, Sandri M, Montesi M, Bresolin S, Cairo S, Buldini B, Locatelli F, Pigazzi M. Borella G, et al. Among authors: buldini b. Blood. 2021 Aug 19;138(7):557-570. doi: 10.1182/blood.2020009845. Blood. 2021. PMID: 34010415 Free article.
84 results